Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPc

Prion diseases are a group of fatal neurodegenerative disorders that affect humans and animals. They are characterized by the accumulation in the central nervous system of a pathological form of the host-encoded prion protein (PrPC). The prion protein is a membrane glycoprotein that consists of two...

Full description

Bibliographic Details
Main Authors: Alessandro Didonna, Anja Colja Venturini, Katrina Hartman, Tanja Vranac, Vladka Čurin Šerbec, Giuseppe Legname
Format: Article
Language:English
Published: PeerJ Inc. 2015-03-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/811.pdf
_version_ 1797417934824407040
author Alessandro Didonna
Anja Colja Venturini
Katrina Hartman
Tanja Vranac
Vladka Čurin Šerbec
Giuseppe Legname
author_facet Alessandro Didonna
Anja Colja Venturini
Katrina Hartman
Tanja Vranac
Vladka Čurin Šerbec
Giuseppe Legname
author_sort Alessandro Didonna
collection DOAJ
description Prion diseases are a group of fatal neurodegenerative disorders that affect humans and animals. They are characterized by the accumulation in the central nervous system of a pathological form of the host-encoded prion protein (PrPC). The prion protein is a membrane glycoprotein that consists of two domains: a globular, structured C-terminus and an unstructured N-terminus. The N-terminal part of the protein is involved in different functions in both health and disease. In the present work we discuss the production and biochemical characterization of a panel of four monoclonal antibodies (mAbs) against the distal N-terminus of PrPC using a well-established methodology based on the immunization of Prnp0/0 mice. Additionally, we show their ability to block prion (PrPSc) replication at nanomolar concentrations in a cell culture model of prion infection. These mAbs represent a promising tool for prion diagnostics and for studying the physiological role of the N-terminal domain of PrPC.
first_indexed 2024-03-09T06:25:47Z
format Article
id doaj.art-4ff3d64b5efc45999357885f609e61d6
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T06:25:47Z
publishDate 2015-03-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-4ff3d64b5efc45999357885f609e61d62023-12-03T11:19:44ZengPeerJ Inc.PeerJ2167-83592015-03-013e81110.7717/peerj.811811Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPcAlessandro Didonna0Anja Colja Venturini1Katrina Hartman2Tanja Vranac3Vladka Čurin Šerbec4Giuseppe Legname5Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, ItalyDepartment for Production of Diagnostic Reagents and Research, Blood Transfusion Centre of Slovenia, Ljubljana, SloveniaDepartment for Production of Diagnostic Reagents and Research, Blood Transfusion Centre of Slovenia, Ljubljana, SloveniaDepartment for Production of Diagnostic Reagents and Research, Blood Transfusion Centre of Slovenia, Ljubljana, SloveniaDepartment for Production of Diagnostic Reagents and Research, Blood Transfusion Centre of Slovenia, Ljubljana, SloveniaDepartment of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, ItalyPrion diseases are a group of fatal neurodegenerative disorders that affect humans and animals. They are characterized by the accumulation in the central nervous system of a pathological form of the host-encoded prion protein (PrPC). The prion protein is a membrane glycoprotein that consists of two domains: a globular, structured C-terminus and an unstructured N-terminus. The N-terminal part of the protein is involved in different functions in both health and disease. In the present work we discuss the production and biochemical characterization of a panel of four monoclonal antibodies (mAbs) against the distal N-terminus of PrPC using a well-established methodology based on the immunization of Prnp0/0 mice. Additionally, we show their ability to block prion (PrPSc) replication at nanomolar concentrations in a cell culture model of prion infection. These mAbs represent a promising tool for prion diagnostics and for studying the physiological role of the N-terminal domain of PrPC.https://peerj.com/articles/811.pdfPrion proteinMonoclonal antibodiesHistopathologyPrion inhibition
spellingShingle Alessandro Didonna
Anja Colja Venturini
Katrina Hartman
Tanja Vranac
Vladka Čurin Šerbec
Giuseppe Legname
Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPc
PeerJ
Prion protein
Monoclonal antibodies
Histopathology
Prion inhibition
title Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPc
title_full Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPc
title_fullStr Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPc
title_full_unstemmed Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPc
title_short Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPc
title_sort characterization of four new monoclonal antibodies against the distal n terminal region of prpc
topic Prion protein
Monoclonal antibodies
Histopathology
Prion inhibition
url https://peerj.com/articles/811.pdf
work_keys_str_mv AT alessandrodidonna characterizationoffournewmonoclonalantibodiesagainstthedistalnterminalregionofprpc
AT anjacoljaventurini characterizationoffournewmonoclonalantibodiesagainstthedistalnterminalregionofprpc
AT katrinahartman characterizationoffournewmonoclonalantibodiesagainstthedistalnterminalregionofprpc
AT tanjavranac characterizationoffournewmonoclonalantibodiesagainstthedistalnterminalregionofprpc
AT vladkacurinserbec characterizationoffournewmonoclonalantibodiesagainstthedistalnterminalregionofprpc
AT giuseppelegname characterizationoffournewmonoclonalantibodiesagainstthedistalnterminalregionofprpc